JP2019509337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509337A5 JP2019509337A5 JP2018562713A JP2018562713A JP2019509337A5 JP 2019509337 A5 JP2019509337 A5 JP 2019509337A5 JP 2018562713 A JP2018562713 A JP 2018562713A JP 2018562713 A JP2018562713 A JP 2018562713A JP 2019509337 A5 JP2019509337 A5 JP 2019509337A5
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- dcm
- solution
- thiadiadinan
- lcms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1603104.9A GB201603104D0 (en) | 2016-02-23 | 2016-02-23 | Therapeutic agents |
| GB1603104.9 | 2016-02-23 | ||
| PCT/EP2017/054023 WO2017144517A1 (en) | 2016-02-23 | 2017-02-22 | Iminothiadiazinane dioxide derivatives as plasmepsin v inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509337A JP2019509337A (ja) | 2019-04-04 |
| JP2019509337A5 true JP2019509337A5 (https=) | 2021-02-04 |
| JP6831400B2 JP6831400B2 (ja) | 2021-02-17 |
Family
ID=55753038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018562713A Active JP6831400B2 (ja) | 2016-02-23 | 2017-02-22 | プラスメプシンｖ阻害薬としてのイミノチアジアジン二量体誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10464932B2 (https=) |
| EP (1) | EP3419975B1 (https=) |
| JP (1) | JP6831400B2 (https=) |
| CN (1) | CN109153674B (https=) |
| BR (1) | BR112018016196A2 (https=) |
| CA (1) | CA3015271C (https=) |
| EA (1) | EA034537B1 (https=) |
| ES (1) | ES2886449T3 (https=) |
| GB (1) | GB201603104D0 (https=) |
| WO (1) | WO2017144517A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| GB201805816D0 (en) | 2018-04-06 | 2018-05-23 | Ucb Biopharma Sprl | Therapeutic agents |
| MX2021003904A (es) | 2018-10-05 | 2021-10-26 | Annapurna Bio Inc | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj. |
| CN110156608B (zh) * | 2019-04-24 | 2022-04-01 | 深圳市第二人民医院 | 绿卡色林中间体对氯苯乙胺的合成方法 |
| GB201906804D0 (en) | 2019-05-14 | 2019-06-26 | Ucb Biopharma Sprl | Therapeutic agents |
| WO2021026884A1 (en) * | 2019-08-15 | 2021-02-18 | Merck Sharp & Dohme Corp. | Antimalarial agents |
| JP7592069B2 (ja) * | 2019-08-19 | 2024-11-29 | ユーシービー バイオファルマ エスアールエル | 抗マラリア性ヘキサヒドロピリミジン類似体 |
| WO2021155612A1 (en) * | 2020-02-09 | 2021-08-12 | Merck Sharp & Dohme Corp. | Antimalarial agents |
| GB202010606D0 (en) | 2020-07-10 | 2020-08-26 | Ucb Biopharma Sprl | Therapeutic agents |
| WO2023102747A1 (en) * | 2021-12-07 | 2023-06-15 | Merck Sharp & Dohme Llc | Antimalarial agents |
| WO2023152042A1 (en) | 2022-02-08 | 2023-08-17 | UCB Biopharma SRL | Antimalarial hexahydropyrimidine analogues |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006527201A (ja) * | 2003-06-06 | 2006-11-30 | スミスクライン・ビーチャム・コーポレイション | Ｉｌ−８受容体アンタゴニスト |
| EP2335701B1 (en) | 2003-12-15 | 2012-07-11 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7592348B2 (en) * | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7763609B2 (en) * | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| UA108363C2 (uk) * | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| JP5735986B2 (ja) * | 2010-01-18 | 2015-06-17 | エムエムヴィ メディシンズ フォア マラリア ヴェンチャーＭｍｖ Ｍｅｄｉｃｉｎｅｓ Ｆｏｒ Ｍａｌａｒｉａ Ｖｅｎｔｕｒｅ | 新規抗マラリア剤 |
| WO2014093190A1 (en) | 2012-12-14 | 2014-06-19 | Merck Sharp & Dohme Corp. | Bace inhibitors of iminothiadiazine dioxides |
-
2016
- 2016-02-23 GB GBGB1603104.9A patent/GB201603104D0/en not_active Ceased
-
2017
- 2017-02-22 JP JP2018562713A patent/JP6831400B2/ja active Active
- 2017-02-22 ES ES17706753T patent/ES2886449T3/es active Active
- 2017-02-22 CA CA3015271A patent/CA3015271C/en active Active
- 2017-02-22 EP EP17706753.5A patent/EP3419975B1/en active Active
- 2017-02-22 US US16/076,387 patent/US10464932B2/en active Active
- 2017-02-22 CN CN201780012863.2A patent/CN109153674B/zh not_active Expired - Fee Related
- 2017-02-22 EA EA201891870A patent/EA034537B1/ru not_active IP Right Cessation
- 2017-02-22 BR BR112018016196A patent/BR112018016196A2/pt active Search and Examination
- 2017-02-22 WO PCT/EP2017/054023 patent/WO2017144517A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509337A5 (https=) | ||
| AU2012322572B2 (en) | Protein kinase inhibitors | |
| AU2018346051B2 (en) | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | |
| ES2391757T3 (es) | Derivados de 1-H-pirrol sustituidos con 1-heterociclilsulfonilo, 2-aminometilo, 5-heteroarilo como inhibidores de la secreción de ácido | |
| CA2648036C (en) | Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor | |
| JP2012519196A5 (https=) | ||
| AU2014209853B2 (en) | Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents | |
| EP2468729A1 (en) | Novel indazole derivative | |
| CA2771026A1 (en) | Indole derivatives as crac modulators | |
| WO2013186334A1 (en) | 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents | |
| AU2016258874B2 (en) | Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors | |
| JP2013515755A5 (https=) | ||
| EP2170875A1 (en) | Aminoalkylazole derivatives as histamine-3 antagonists | |
| EP2970163A1 (en) | 5-thiazolecarboxamide dervatives and their use as btk inhibitors | |
| WO2013190455A2 (en) | Process for the preparation of lurasidone hydrochloride | |
| TW202502770A (zh) | 用於製備ｉｒａｋ４抑制劑之程序 | |
| WO2012174685A1 (zh) | 一种2-取代-2h-1，2，3-三氮唑衍生物的制备方法 | |
| KR20070085371A (ko) | 페녹시 벤즈아미드 화합물의 제조 방법 | |
| CN119866333A (zh) | Kit抑制剂、化合物、药物组合物及其使用方法 | |
| TW202428265A (zh) | Kit抑制劑、化合物、醫藥組合物、及其使用方法 | |
| AU2011308256B2 (en) | Novel method of preparing benzoimidazole derivatives | |
| JP2004196678A (ja) | ピラゾール系誘導体 | |
| WO2016143655A1 (ja) | １，２，４－オキサジアゾール誘導体の製造方法 | |
| Wang et al. | Safe and highly efficient syntheses of triazole drugs using Cu2O nanoparticle in aqueous solutions | |
| WO2012061169A1 (en) | Benzimidazole inhibitors of leukotriene production |